These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Hydroxy metabolites of tricyclic antidepressants: evaluation of relative cardiotoxicity. Pollock BG; Perel JM Psychopharmacol Ser; 1989; 7():232-6. PubMed ID: 2687861 [No Abstract] [Full Text] [Related]
7. [Depressed patients and their treatment. Therapeutic mistakes and toxicity (author's transl)]. Crome P Encephale; 1981; 7(4 Suppl):499-506. PubMed ID: 7318762 [TBL] [Abstract][Full Text] [Related]
8. Mianserin, agranulocytosis, and suicide. Thomas CS; Read DA Lancet; 1990 Dec; 336(8729):1511. PubMed ID: 1979118 [No Abstract] [Full Text] [Related]
9. The problem of side effects: cardiotoxicity. Agnoli A; Martucci N; Ciabatti P; Caratozzolo P; Rulli V; Sollecito A Adv Biochem Psychopharmacol; 1982; 32():375-81. PubMed ID: 7090903 [No Abstract] [Full Text] [Related]
10. [Letter: Cardiotoxicity of tricyclic thymoleptics]. Moccetti T Dtsch Med Wochenschr; 1976 Sep; 101(37):1370-1. PubMed ID: 954597 [No Abstract] [Full Text] [Related]
11. Cardiac effects of nortriptyline and other tricyclic antidepressant drugs. Bonaccorsi A; Garattini S Gen Pharmacol; 1978; 9(2):81-4. PubMed ID: 350699 [No Abstract] [Full Text] [Related]
12. Phenytoin: the drug of choice in tricyclic antidepressant overdose? Uhl JA Ann Emerg Med; 1981 May; 10(5):270-4. PubMed ID: 7224279 [TBL] [Abstract][Full Text] [Related]
17. Possible mirtazapine-induced rhabdomyolysis. Khandat AB; Nurnberger JI; Shekhar A Ann Pharmacother; 2004; 38(7-8):1321. PubMed ID: 15187213 [No Abstract] [Full Text] [Related]
18. A controlled study of the efficacy and safety of mianserin and amitriptyline in depressive inpatients. Möller HJ; Kasper S; Müller H; Kissling W; Fuger J; Ruhrmann S Pharmacopsychiatry; 1995 Nov; 28(6):249-52. PubMed ID: 8773291 [TBL] [Abstract][Full Text] [Related]